FHEFD - Artículos

Preguntas frecuentes Manual de uso Derechos de autor Contacto/Sugerencias

Listar por

Por fecha de publicación Autores Títulos Materias Tipo de publicación Centros

Envíos recientes

EEG abnormalities and clinical phenotypes in pre-school children with autism spectrum disorder

Romero-González, Marina; Navas-Sánchez, Patricia; Marín-Gámez, Ester; Barbancho-Fernandez, Miguel Angel; Fernández Sánchez, Victoria Eugenia; [et al.] (Elsevier, 2022-04)

Abnormalities on electroencephalography (EEG) results have been reported in a high percentage of children with Autism Spectrum Disorder (ASD). The purpose of this study was to explore the prevalence of EEG abnormalities ...
The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression

Cantero-García, Noelia; Flores-Burgess, Antonio; Ladrón de Guevara-Miranda, David; Serrano, Antonia; García-Durán, Laura; [et al.] (MDPI, 2022)
Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression

Flores-Burgess, Antonio; Millón, Carmelo; Gago, Belén; García- Durán, Laura; Cantero-García, Noelia; [et al.] (2021)
Galanin (1-15) potentiates the antidepres-sant-like effects induced by Escitalopram in a rat model of depression

García-Durán, Laura; Flores-Burgess, Antonio; Cantero-García, Noelia; Puigcerver-Martinez, Araceli; Narváez, José Ángel; [et al.] (2021-10-07)

Selective 5-HT reuptake inhibitor antidepressants (SSRIs) are the first choice in major depressive disorder (MDD), but 50% of affected patients do not show improvement. Galanin(1-15) [GAL(1-15)] enhanced Fluoxetine ...
Central administration of Galanin-N terminal fragment 1-15 decreases the voluntary alcohol intake in rats

Millón, Carmelo; Flores-Burgess, Antonio; Castilla-Ortega, Estela; Gago, Belén; García-Fernandez, María; [et al.] (2019)
The neuropeptides Galanin and Galanin (1-15) in depression-like behaviours

Millón, Carmelo; Flores-Burgess, Antonio; Narváez, Manuel; Borroto-Escuela, Dasiel; Gago, Belén; [et al.] (2017)
Role of the Galanin N--terminal fragment (1-15) in anhedonia: involvement of the dopaminergic mesolimbic system

Millón, Carmelo; Flores-Burgess, Antonio; Gago, Belén; Alén, Francisco; Orio, Laura; [et al.] (2019)
Galanin (1-15) - Fluoxetine interaction in the novel object recognition test involvement of 5-HT1A receptors in the prefrontal cortex of the rats

Flores-Burgess, Antonio; Millón, Carmelo; Gago, Belén; García- Durán, Laura; Cantero-García, Noelia; [et al.] (2019)
GALANIN (1-15) ENHANCEMENT OF THE BEHAVIORAL EFFECTS OF FLUOXETINE IN THE FORCED SWIMMING TEST GIVES A NEW THERAPEUTIC STRATEGY AGAINST DEPRESSION.

Flores-Burgess, Antonio; Millón, Carmelo; Gago, Belén; Narváez, Manuel; Borroto-Escuela, Dasiel; [et al.] (2017)

FHEFD - Artículos

Listar por

Envíos recientes

EEG abnormalities and clinical phenotypes in pre-school children with autism spectrum disorder ﻿

The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression ﻿

Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression ﻿

Galanin (1-15) potentiates the antidepres-sant-like effects induced by Escitalopram in a rat model of depression ﻿

Central administration of Galanin-N terminal fragment 1-15 decreases the voluntary alcohol intake in rats ﻿

The neuropeptides Galanin and Galanin (1-15) in depression-like behaviours ﻿

Role of the Galanin N--terminal fragment (1-15) in anhedonia: involvement of the dopaminergic mesolimbic system ﻿

Galanin (1-15) - Fluoxetine interaction in the novel object recognition test involvement of 5-HT1A receptors in the prefrontal cortex of the rats ﻿

GALANIN (1-15) ENHANCEMENT OF THE BEHAVIORAL EFFECTS OF FLUOXETINE IN THE FORCED SWIMMING TEST GIVES A NEW THERAPEUTIC STRATEGY AGAINST DEPRESSION. ﻿

EEG abnormalities and clinical phenotypes in pre-school children with autism spectrum disorder

The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression

Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression

Galanin (1-15) potentiates the antidepres-sant-like effects induced by Escitalopram in a rat model of depression

Central administration of Galanin-N terminal fragment 1-15 decreases the voluntary alcohol intake in rats

The neuropeptides Galanin and Galanin (1-15) in depression-like behaviours

Role of the Galanin N--terminal fragment (1-15) in anhedonia: involvement of the dopaminergic mesolimbic system

Galanin (1-15) - Fluoxetine interaction in the novel object recognition test involvement of 5-HT1A receptors in the prefrontal cortex of the rats

GALANIN (1-15) ENHANCEMENT OF THE BEHAVIORAL EFFECTS OF FLUOXETINE IN THE FORCED SWIMMING TEST GIVES A NEW THERAPEUTIC STRATEGY AGAINST DEPRESSION.